Presenter: Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center Faculty, Family Medicine Residency, Advocate Lutheran General Hospital
Online CME Credit
Fee: $50.00
Provides 1.00 hour of CE/CME credit (Presented on July 2, 2024; Reviewed January 11, 2024; Expires December 31, 2027)
The life expectancy of people with Down syndrome has doubled over the last 40 years. The number of people with Down syndrome living into adulthood has also increased significantly. In this presentation, Brian Chicoine, MD, will review the health care changes, past and present, that contributed to these changes. He will also describe differences in the prevalence of health conditions in adolescents and adults with Down syndrome compared to those without Down syndrome and discuss how these differences may affect health promotion and health care of people with Down syndrome. Additionally, Dr. Chicoine will describe the effects of bias in health care of people with Down syndrome and provide suggestions for supporting individuals with Down syndrome in receiving high-quality care.
This program is supported by the Down Syndrome Network of Northern Nevada (DSNNN) and the Katerini Zoe Medical Outreach Program.
The DSNNN is a community of families, friends, and individuals committed to providing information, education, and support while raising awareness of Down syndrome in Northern Nevada. Through their work supporting families, a deep bond was formed with the Butler family. In February 2022, after a short battle with leukemia and surrounded by her parents, their precious daughter, Katerini, passed away. To honor her memory, the Butler family established the Katerini Zoe Medical Outreach Program. This program’s mission is to support families by collaborating with healthcare providers to enhance family-centered care and deepen understanding of the many aspects of serving patients with Down syndrome.
Following participation in this course, participants should be able to:
Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center, Faculty, Family Medicine Residency, Advocate Lutheran General Hospital
For questions or inquiries regarding this program series, please contact cme@med.unr.edu.
CE/CME Certificate - Cost is $0.00
Instructions for receiving CME/CE credit:
For questions concerning the online evaluation or your certificate, please contact our office at (775) 784-4791 or email us at cme@med.unr.edu.
This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nevada, Reno School of Medicine and Down Syndrome Network of Northern Nevada (DSNNN). The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.
The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nevada, Reno School of Medicine approves this program for 1.00 hours of nursing continuing education credit. Nevada State Board of Nursing provider number 120894-1.
This program provides 1 CME credit towards the Nevada State Board of Medical Examiners' requirement for 2 hours of training related to ethics, pain management, or addiction care during each licensure period.
As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of an accredited activity disclose all financial relationships within the prior 24 months with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All relevant financial relationships have been mitigated. Following are those disclosures.
All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that they do not have financial relationships with ineligible companies related to the content of this activity.
Alagoz O, Hajjar A, Chootipongchaivat S, et al. Benefits and harms of mammography screening for women with Down syndrome: A collaborative modeling study. J Gen Intern Med. 2019;34(11):2374-2381. doi:10.1007/s11606-019-05182-5
Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol. 2004;46(4):282-286. doi:10.1017/s0012162204000441
Chicoine B, Kirschner KL. Considering dignity of risk in the care of people with intellectual disabilities: A clinical perspective. Perspect Biol Med. 2022;65(2):189-198. doi:10.1353/pbm.2022.0014
Chicoine B, Rivelli A, Fitzpatrick V, Chicoine L, Jia G, Rzhetsky A. Prevalence of common disease conditions in a large cohort of individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2021;8(2):86-97. Published 2021 Apr 19. doi:10.17294/2330-0698.1824
Chicoine C, Hickey EE, Kirschner KL, Chicoine BA. Ableism at the Bedside: People with Intellectual Disabilities and COVID-19. J Am Board Fam Med. 2022;35(2):390-393. doi:10.3122/jabfm.2022.02.210371
Coppus AM, Evenhuis HM, Verberne GJ, et al. Survival in elderly persons with Down syndrome. J Am Geriatr Soc. 2008;56(12):2311-2316. doi:10.1111/j.1532-5415.2008.01999.x
de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in Europe. Eur J Hum Genet. 2021;29;402-410. doi:10.1038/s41431-020-00748-y
Fitzpatrick V, Rivelli A, Bria K, Chicoine B. Heart disease in adults with Down syndrome between 1996 and 2016. J Am Board Fam Med. 2020;33(6):923-931. doi:10.3122/jabfm.2020.06.190425
Fitzpatrick V, Rivelli A, Chaudhari S, et al. Prevalence of infectious diseases among 6078 individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2022;9(1):64-69. Published 2022 Jan 17. doi:10.17294/2330-0698.1876
Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH. The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet. 2002;62(5):390-393. doi:10.1034/j.1399-0004.2002.620506.x
Hallyburton A. Diagnostic overshadowing: An evolutionary concept analysis on the misattribution of physical symptoms to pre-existing psychological illnesses. Int J Ment Health Nurs. 2022;31(6):1360-1372. doi:10.1111/inm.13034
Iezzoni LI, Rao SR, Ressalam J, et al. Physicians’ perceptions of people with disability and their health care. Health Aff (Millwood). 2021;40(2):297-306. doi:10.1377/hlthaff.2020.01452
Lagu T, Haywood C, Reimold K, DeJong C, Walker Sterling R, Iezzoni LI. ‘I am not the doctor for you': Physicians’ attitudes about caring for people with disabilities. Health Aff (Millwood). 2022;41(10):1387-1395. doi:10.1377/hlthaff.2022.00475
Lazris A, Roth A, Haskell H, James J. Diagnostic overshadowing: When cognitive biases can harm patients. Am Fam Physician. 2023;108(3):292-294.
Molloy R, Munro I, Pope N. Understanding the experience of diagnostic overshadowing associated with severe mental illness from the consumer and health professional perspective: A qualitative systematic review protocol. JBI Evid Synth. 2021;19(6):1362-1368. doi:10.11124/JBIES-20-00244
Perske R. The dignity of risk and the mentally retarded. Ment Retard. 1972;10(1):24-27.
Rader R, McGaffigan P. Diagnostic overshadowing worsens health disparities. The Joint Commission. July 22, 2022. Accessed June 26, 2025. https://www.jointcommission.org/resources/news-and-multimedia/blogs/advancing-health-care-equity/2022/07/diagnostic-overshadowing-worsens-health-disparities/
Rivelli A, Fitzpatrick V, Chaudhari S, et al. Prevalence of mental health conditions among 6078 individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2022;9(1):58-63. Published 2022 Jan 17. doi:10.17294/2330-0698.1875
Rivelli A, Fitzpatrick V, Wales D, et al. Prevalence of endocrine disorders among 6078 individuals With Down syndrome in the United States. J Patient Cent Res Rev. 2022;9(1):70-74. Published 2022 Jan 17. doi:10.17294/2330-0698.1877
Santoro JD, Patel L, Kammeyer R, et al. Assessment and diagnosis of Down syndrome regression disorder: International expert consensus. Front. Neurol. 2022;13.940175. doi:10.3389/fneur2022.940175
Sobey CG, Judkins CP, Sundararajan V, et al. Risk of major cardiovascular events in people with Down syndrome. PLoS One. 2015;10(9):e0137093. doi:10.1371/journal.pone.0137093
Tsou AY, Bulova P, Capone G, et al. Medical care of adults with Down syndrome: A clinical guideline. JAMA. 2020;324(15):1543-1556. doi:10.1001/jama.2020.17024
Zhu JL, Hasle H, Correa A, et al. Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med. 2013;15(1):64-69. doi:10.1038/gim.2012.93